DE69126701T2 - Multifunktionelle pharmazeutische verbindungen und verfahren zu ihrer verwendung - Google Patents

Multifunktionelle pharmazeutische verbindungen und verfahren zu ihrer verwendung

Info

Publication number
DE69126701T2
DE69126701T2 DE69126701T DE69126701T DE69126701T2 DE 69126701 T2 DE69126701 T2 DE 69126701T2 DE 69126701 T DE69126701 T DE 69126701T DE 69126701 T DE69126701 T DE 69126701T DE 69126701 T2 DE69126701 T2 DE 69126701T2
Authority
DE
Germany
Prior art keywords
oxo
ait
purin
dihydro
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69126701T
Other languages
German (de)
English (en)
Other versions
DE69126701D1 (de
Inventor
Alvin J. Tustin Calif. Glasky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69126701D1 publication Critical patent/DE69126701D1/de
Publication of DE69126701T2 publication Critical patent/DE69126701T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69126701T 1990-03-28 1991-03-26 Multifunktionelle pharmazeutische verbindungen und verfahren zu ihrer verwendung Expired - Fee Related DE69126701T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/500,789 US5091432A (en) 1990-03-28 1990-03-28 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
PCT/US1991/002066 WO1991014434A1 (en) 1990-03-28 1991-03-26 Multi-functional pharmaceutical compounds and methods of use

Publications (2)

Publication Number Publication Date
DE69126701D1 DE69126701D1 (de) 1997-08-07
DE69126701T2 true DE69126701T2 (de) 1997-12-04

Family

ID=23990941

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69126701T Expired - Fee Related DE69126701T2 (de) 1990-03-28 1991-03-26 Multifunktionelle pharmazeutische verbindungen und verfahren zu ihrer verwendung

Country Status (17)

Country Link
US (1) US5091432A (https=)
EP (1) EP0522082B1 (https=)
JP (1) JP3198335B2 (https=)
KR (1) KR100194162B1 (https=)
AT (1) ATE154880T1 (https=)
AU (1) AU7678191A (https=)
CA (1) CA2079342C (https=)
CS (1) CS85991A3 (https=)
DE (1) DE69126701T2 (https=)
DK (1) DK0522082T3 (https=)
ES (1) ES2104700T3 (https=)
GR (1) GR3024904T3 (https=)
IE (1) IE81123B1 (https=)
IL (1) IL97638A (https=)
NZ (1) NZ237574A (https=)
TW (1) TW279865B (https=)
WO (1) WO1991014434A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801184A (en) * 1994-07-25 1998-09-01 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
FI970302L (fi) * 1994-07-25 1997-01-24 Alvin J Glasky Hiilimonoksidista riippuvaisia guanylyylisyklaasin modifikaattoreita
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US5447939A (en) * 1994-07-25 1995-09-05 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
WO1999057119A1 (en) * 1998-05-04 1999-11-11 Neotherapeutics, Inc. Novel dopamine-like 9-substituted hypoxanthine and methods of use
US6303617B1 (en) * 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6686370B2 (en) * 1999-12-06 2004-02-03 Euro-Celtique S.A. Triazospiro compounds having nociceptin receptor affinity
US6407237B1 (en) * 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
US20020128264A1 (en) * 2000-07-07 2002-09-12 Taylor Eve M. Methods for treatment of conditions affected by activity of multidrug transporters
EP1790344B1 (en) * 2000-07-07 2011-02-23 Spectrum Pharmaceuticals, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US20020040032A1 (en) * 2000-07-07 2002-04-04 Glasky Michelle S. Methods for stimulation of synthesis of synaptophysin in the central nervous system
US20020040031A1 (en) * 2000-07-07 2002-04-04 Glasky Michelle S. Methods for prevention of accumulation of amyloid beta peptide in the central nervous system
US20020091133A1 (en) * 2000-12-12 2002-07-11 Eve M. Taylor Use of 9-substituted purine analogues and other molecules to stimulate neurogenesis
US20020156277A1 (en) * 2001-04-20 2002-10-24 Fick David B. Synthesis and methods of use of purine analogues and derivatives
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US6906190B2 (en) * 2002-01-04 2005-06-14 Ribapharm Inc. Inhibitors for de novo-RNA polymerases and methods of identifying targets for same
EP2338490A3 (en) 2003-11-03 2012-06-06 Probiodrug AG Combinations useful for the treatment of neuronal disorders
US7473728B2 (en) * 2004-12-16 2009-01-06 The Goodyear Tire & Rubber Company Dual phase rubber composition and tire with nanocomposite-containing sidewall thereof
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
EP1968561B8 (en) * 2005-12-22 2010-10-20 Kiacta Sàrl Treatment of diabetic nephropathy
PT2089417E (pt) * 2006-10-12 2015-04-14 Bhi Ltd Partnership Métodos, compostos, composições e veículos para administrar o ácido 3-amino-1-propanossulfónico
WO2008078176A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
US9593126B2 (en) 2012-11-21 2017-03-14 Zoetis Services Llc Synthesis of spirocyclic isoxazoline derivatives
CN115521306B (zh) * 2022-09-26 2024-03-26 贵州大学 一种1,2,3,4-四氢-β-咔啉衍生物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321369A (en) * 1965-05-26 1967-05-23 Abbott Lab Method of enhancing learning rate and retention level in warm blooded animals
US3484521A (en) * 1966-06-23 1969-12-16 Int Chem & Nuclear Corp Enhancement of memory processes in mammals with basic addition salts of ribonucleic acid
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US4728605A (en) * 1984-07-31 1988-03-01 Fudenberg Herman H Methods for recognizing and diagnosing subsets of Alzheimer's disease associated with immune system dysfunction, and for the in vitro testing of possible therapeutic agents for treatment of same
US4952693A (en) * 1984-10-12 1990-08-28 Warner-Lambert Company Oxazolo-pyrimidine derivatives

Also Published As

Publication number Publication date
AU7678191A (en) 1991-10-21
CA2079342A1 (en) 1991-09-29
EP0522082A1 (en) 1993-01-13
IE910994A1 (en) 1991-10-09
CS85991A3 (en) 1992-02-19
IL97638A (en) 1999-03-12
ES2104700T3 (es) 1997-10-16
ATE154880T1 (de) 1997-07-15
EP0522082B1 (en) 1997-07-02
JPH05508390A (ja) 1993-11-25
KR100194162B1 (ko) 1999-06-15
IE81123B1 (en) 2000-03-22
TW279865B (https=) 1996-07-01
CA2079342C (en) 2001-10-23
WO1991014434A1 (en) 1991-10-03
DK0522082T3 (da) 1997-07-21
NZ237574A (en) 1993-09-27
GR3024904T3 (en) 1998-01-30
IL97638A0 (en) 1992-06-21
JP3198335B2 (ja) 2001-08-13
US5091432A (en) 1992-02-25
DE69126701D1 (de) 1997-08-07
EP0522082A4 (en) 1993-06-09

Similar Documents

Publication Publication Date Title
DE69126701T2 (de) Multifunktionelle pharmazeutische verbindungen und verfahren zu ihrer verwendung
DE69631330T2 (de) C-4' modifizierte adenosinkinaseinhibitoren
DE69633860T2 (de) Oral aktive adenosinkinase-inhibitoren
DE60315615T2 (de) Tricyclische verbindungen basierend auf thiophen und arzneimittel, die diese umfassen
DE69625175T2 (de) Krebsmittel auf basis von cyclopropylpyrroloindol-oligopeptiden
DE69524114T2 (de) Naphthyridinonderivate
DE102008027331A1 (de) Verwendung von Indol-3-carbonsäureestern zur Hemmung der mikrosomalen Prostaglandin E2 Synthase
DE69433161T2 (de) O6-substituierte guaninederivate, verfahren zu ihre herstellung und ihre anwendung für behandlung von tumorzellen
DE69925462T2 (de) Substituierte cycloalkyl-4-oxonicotinische karboxamide; gaba gehirn-rezeptorligande
DE3752109T2 (de) Entzündungshemmende Mittel
DE69916627T2 (de) 5-heterozyklyl-pyrazolo[4,3-d]pyrimidin-7-one für die behandlung von männlichen erectilen dysfunktionen
DE2653257C2 (https=)
DE2162011C3 (de) 2-Phenyl-3-(4-methyl-piperazinocarbonyloxy)-1-isoindolinon-derivate, ihre Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US12246012B2 (en) Method for treating nervous system injuries using boldine and derivatives thereof
DE60026883T2 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE69726749T2 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
DE2512609A1 (de) Pharmazeutische zubereitung
EP0070084A2 (en) Imidazoline derivatives
DE60013326T2 (de) Verbindungen und verfahren zur behandlung von schmerz
DE2348973C3 (de) 1 -(m-Trifluormethylphenyl)-4-propyIpiperazin-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69826881T2 (de) Neue indolcarboxamide, pharmazeutische zusammensetzungen und methoden zur hemmung von calpain
JP2002515050A (ja) ヘテロ環式チオエステルのｎ−結合尿素およびカルバメート
DE2513136C3 (de) N-(1-Benzylpiperid-4-yl)-benzamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE69909592T2 (de) Verwendung von thiadiazolo[4,3-a]pyridine derivaten
DE69107874T2 (de) Imidazolderivate und diese Imidazolderivate als Wirkstoffe enthaltende Antiepileptika.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee